close
close

Financial Survey of Boston Scientific (NYSE:BSX) and Tenon Medical (NASDAQ:TNON).


Boston Scientific (NYSE:BSX – Get Free Report) and Tenon Medical (NASDAQ:TNON – Get Free Report) are both medical companies, but which is the superior sector? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability.

Valuation and profit

This table compares the gross sales, earnings per share (EPS) and valuation of Boston Scientific and Tenon Medical.

Gross income Price/sales ratio Net income Profit per share Price/earnings ratio
Boston Scientific $14.24 billion 6.95 $1.59 billion $1.07 63.01
Tenon Medical $2.93 million 0.95 -$15.58 million ($9.74) -0.08

Boston Scientific has higher revenues and earnings than Tenon Medical. Tenon Medical trades at a lower price-to-earnings ratio than Boston Scientific, indicating it is currently the more affordable of the two stocks.

Insider and institutional ownership

89.1% of Boston Scientific shares are owned by institutional investors. By comparison, 22.7% of Tenon Medical shares are held by institutional investors. 0.5% of Boston Scientific shares are owned by company insiders. By comparison, 8.4% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market in the long term.

Volatility and risk

Boston Scientific has a beta of 0.78, which suggests its stock price is 22% less volatile than the S&P 500. In comparison, Tenon Medical has a beta of 2.24, which suggests its stock price is 124% more volatile than the S&P 500.

Profitability

This table compares the net margins, return on equity, and return on assets of Boston Scientific and Tenon Medical.

Net margins Return on equity Return on assets
Boston Scientific 11.19% 15.99% 8.87%
Tenon Medical -532.14% -934.11% -200.10%

Analyst Ratings

This is a summary of recent ratings and recommendations for Boston Scientific and Tenon Medical, as provided by MarketBeat.com.

Sales reviews Hold reviews Buy reviews Strong Buy Ratings Review score
Boston Scientific 0 1 18 1 3:00 am
Tenon Medical 0 0 1 0 3:00 am

Boston Scientific currently has a consensus target price of $68.50, indicating a potential upside of 1.60%. Tenon Medical has a consensus price of $3.00, indicating a potential upside of 300.00%. Given Tenon Medical’s higher potential upside, analysts clearly believe that Tenon Medical is more favorable than Boston Scientific.

Resume

Boston Scientific beats Tenon Medical on 11 of the 14 factors comparing the two stocks.

About Boston Scientific

(Get a free report)

Boston Scientific Corporation develops, manufactures and markets medical devices for use in various interventional medical specialties worldwide. It works through two segments, MedSurg and Cardiovascular. The company offers devices for diagnosing and treating gastrointestinal and pulmonary diseases, such as resolution clips, biliary stent systems, stents and electrocautery-enhanced delivery systems, direct visualization systems, digital catheters and single-use duodenoscopes; devices for the treatment of urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as a spinal cord stimulator system, proprietary programming software, a radio frequency generator, indirect decompression systems, exercise optimization tools and a deep brain stimulation system. It also offers technologies for diagnosing and treating coronary artery disease and aortic valve disease; WATCHMAN FLX, a left atrial appendage closure device; and implantable devices that monitor the heart and provide electricity to treat heart defects, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, systems for remote patient management, insertable cardiac monitoring systems and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of cardiac arrhythmias; peripheral arterial and venous diseases; and products to diagnose, treat and alleviate cancers. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

About Tenon Medical

(Get a free report)

Tenon Medical, Inc., a medical device company, develops surgical implant systems for the treatment of severe low back pain in the United States and Puerto Rico. The company offers CATAMARAN SI joint fusion system to fuse sacroiliac joints (SI joints) to treat SI joint dysfunction that often causes severe lower back pain; and features a fixation device that passes through the axial and sagittal planes of the ilium and sacrum, stabilizing and fixing the sacroiliac joints. Tenon Medical, Inc. was founded in 2012 and is headquartered in Los Gatos, California.



Get news and reviews for Boston Scientific Daily – Enter your email address below to receive a daily digest of the latest news and analyst ratings for Boston Scientific and related companies with MarketBeat.com’s FREE daily email newsletter.